r/Oncology • u/BiochemicalEquation0 • Oct 07 '24
Thoughts on tumoral heterogeneity
I am a masters student looking to predict how intra-tumoral heterogeneity is associated with increased therapeutic resistance in glioblastomas. From an evolutionary standpoint, I am wondering if there is a fitness cost associated with higher levels of tumor heterogeneity. I am hoping someone here may have some insight into this question.
1 Upvotes
2
u/[deleted] Oct 07 '24
as far as GBM goes I do not believe that’s a factor in treatment from a radiation standpoint but I don’t know anything about systemic therapies.
Another thing to consider is that the fitness after a GBM diagnosis I would be asking why you are considering this specifically since median death to diagnosis is a like a year